Active substanceDeproteinized hemoderivatDeproteinized hemoderivat
Similar drugsTo uncover
  • Actovegin®
    solution d / infusion 
  • Actovegin®
    solution for injections 
  • Actovegin
    solution for injections 
    Nycomed Austria GmbH     Austria
  • Actovegin
    pills inwards 
  • Actovegin®
    solution d / infusion 
    Nycomed Austria GmbH     Austria
  • Actovegin®
    ointment externally 
  • Actovegin®
    gel externally 
  • Actovegin®
    cream externally 
  • Solcoseryl
    ointment externally 
  • Solcoseryl
    gel externally 
  • Solcoseryl
    solution w / m in / in 
  • Solcoseryl
    gel d / eye 
  • Dosage form: & nbspcream for external use
    Composition:

    100 g of cream contain:

    active substance: blood components - deproteinized hemoderivat of calves' blood: 5 ml (corresponding to 0.2 g of dry mass);

    Excipients: macrogol 400, macrogol 4000, cetyl alcohol, glyceryl monostearate, benzalkonium chloride, purified water.

    Description:A homogeneous cream of white color.
    Pharmacotherapeutic group:Regeneration of tissue stimulant
    ATX: & nbsp
  • Other preparations for the treatment of skin diseases
  • Pharmacodynamics:

    ACTOVEGIN ® - antihypoxant, activates the metabolism of glucose and oxygen. ACTOVEGIN® causes an increase in cellular energy metabolism. Its activity is confirmed by increased consumption and increased utilization of glucose and oxygen by cells. These two effects are conjugate, they cause an increase in the metabolism of ATP and, consequently, increase energy metabolism. The result is the stimulation and acceleration of the healing process, characterized by increased energy consumption.

    Indications:
    • Wounds and inflammatory diseases of the skin and mucous membranes, such as: burns, including sun, skin cuts, abrasions, scratches.
    • In order to improve tissue regeneration after burns, including after burning with boiling liquid or steam.
    • Ulcers of varicose origin or other soaking ulcers.
    • For the prevention and treatment of decubitus.
    • For the prevention and treatment of reactions from the skin and mucous membranes caused by exposure to radiation.
    Contraindications:

    Hypersensitivity to the drug ACTOVEGIN® or similar drugs.

    Pregnancy and lactation:

    Application in pregnancy and lactation is allowed.

    Dosing and Administration:
    Outwardly.

    The course of treatment is at least 12 days and continues throughout the period of active regeneration. Multiplicity of application - at least 2 times a day.

    Ulcers: After the initial therapy with ACTOVEGIN® 20% in the form of a gel, apply ACTOVEGIN® 5% cream with a thin layer.

    For prophylaxis of pressure sores: cream rubbed into the skin in areas of increased risk

    In order to prevent the occurrence of radiation damage: ACTOVEGIN® 5% cream is applied a thin layer immediately after radiation therapy and in intervals between sessions.

    In the absence or inadequacy of the effect of the application of ACTOVEGIN® 5% in the form of a cream should consult a doctor.

    Side effects:

    Usually the drug is well tolerated.

    In patients who have a history of hypersensitivity reactions, in rare cases, allergic reactions may develop.

    Interaction:

    It is currently unknown.

    Form release / dosage:

    Cream for external use 5%.

    Packaging:

    For 20 grams, 30 grams, 50 grams, 100 grams in aluminum tubes with the control of the first opening and a plastic lid. 1 tube with instructions for use is placed in a cardboard box.

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children!

    Shelf life:

    5 years. Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N014635 / 05
    Date of registration:14.03.2008 / 22.03.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:NIKOMED DISTRIBUTION Sente, LLC NIKOMED DISTRIBUTION Sente, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp29.06.2017
    Illustrated instructions
      Instructions
      Up